NasdaqGM:ATRCMedical Equipment
Does AtriCure's (ATRC) cryoXT Launch Signal a Shift in Pain Management Innovation?
AtriCure, Inc. recently launched the cryoXT device, an FDA 510(k)-cleared cryoablation technology designed to manage post-operative pain after amputation by ablating peripheral nerves.
The cryoXT device introduces multi-surface freezing technology to the cryoICE platform, addressing significant clinical needs for patients suffering from residual and phantom limb pain after amputation.
We'll explore how the introduction of cryoXT as an innovative pain management solution could reshape...